» Authors » Anneli Uuskula

Anneli Uuskula

Explore the profile of Anneli Uuskula including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 143
Citations 1161
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Uuskula A, Tisler A, DeHovitz J, Murenzi G, Castle P, Clifford G
Lancet HIV . 2025 Mar; PMID: 40086453
The advent of effective antiretroviral therapy (ART) has increased the lifespan of many people living with HIV. As a result, cancers driven by high-risk human papillomavirus (HPV) infection have emerged...
2.
Remmel M, Suija K, Markina A, Tisler A, kivite-Urtane A, Stankunas M, et al.
PLoS One . 2025 Mar; 20(3):e0317986. PMID: 40043044
Background: The development of risk-based cancer screening programs requires a paradigm shift in existing practices and healthcare policies. Therefore, it is crucial to not only assess the effectiveness of new...
3.
Boje R, Bardou M, Mensah K, Rico Berrocal R, Bonvicini L, Iorio G, et al.
BMJ Open . 2025 Jan; 15(1):e090631. PMID: 39863407
Objective: This study explored and compared stakeholder perspectives on enhancements to cervical cancer screening for vulnerable women across seven European countries. Design: In a series of Collaborative User Boards, stakeholders...
4.
Savulescu C, Prats-Uribe A, Brolin K, Uuskula A, Bergin C, Fleming C, et al.
Vaccine . 2024 Dec; 45:126615. PMID: 39724693
Introduction: Repeated COVID-19 booster vaccination was recommended in healthcare workers (HCWs) to maintain protection. We measured the relative vaccine effectiveness (rVE) of the second booster dose of COVID-19 vaccine compared...
5.
Savulescu C, Prats-Uribe A, Brolin K, Makaric Z, Uuskula A, Panagiotakopoulos G, et al.
Vaccines (Basel) . 2024 Nov; 12(11). PMID: 39591197
European countries have included healthcare workers (HCWs) among priority groups for COVID-19 vaccination. We established a multi-country hospital network to measure the SARS-CoV-2 incidence and effectiveness of COVID-19 vaccines among...
6.
Xie J, Lopez-Guell K, Dedman D, Duarte-Salles T, Kolde R, Lopez-Blasco R, et al.
EClinicalMedicine . 2024 Nov; 77:102903. PMID: 39552716
Background: The World Health Organisation (WHO) has identified a range of symptomatic manifestations to aid in the clinical diagnosis of post-COVID conditions, herein referred to as post-acute COVID-19 symptoms. We...
7.
Savulescu C, Prats-Uribe A, Brolin K, Uuskula A, Bergin C, Fleming C, et al.
Euro Surveill . 2024 Nov; 29(44). PMID: 39484687
COVID-19 vaccination recommendations include healthcare workers (HCWs). We measured COVID-19 vaccine effectiveness (CVE) of the autumn 2023 dose against laboratory-confirmed SARS-CoV-2 infection in a prospective cohort study of 1,305 HCWs...
8.
Remmel M, Suija K, Raudne R, Tisler A, kivite-Urtane A, Stankunas M, et al.
BMC Cancer . 2024 Oct; 24(1):1314. PMID: 39455985
Background: The increased knowledge of cervical cancer (CC) risk factors and suboptimal performance of present screening programs has generated interest in shifting from a universal screening approach to one based...
9.
Tisler A, Vork A, Tammemagi M, Ojavee S, Raag M, Savrova A, et al.
Sci Rep . 2024 Oct; 14(1):24589. PMID: 39426992
Transitioning to an individualized risk-based approach can significantly enhance cervical cancer screening programs. We aimed to derive and internally validate a prediction model for assessing the risk of cervical intraepithelial...
10.
Tisler A, Toompere K, Bardou M, Diaz J, Orumaa M, Uuskula A
Eur J Public Health . 2024 Oct; 34(6):1199-1204. PMID: 39378418
Cancers represent the primary cause of mortality among people living with HIV (PLWH). However, comprehensive nationwide data regarding cancer incidence remains limited. Our objective was to evaluate the incidence rates...